Viewing Study NCT00522834


Ignite Creation Date: 2025-12-25 @ 2:34 AM
Ignite Modification Date: 2025-12-26 @ 1:10 AM
Study NCT ID: NCT00522834
Status: TERMINATED
Last Update Posted: 2014-03-04
First Post: 2007-08-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma
Sponsor: Synta Pharmaceuticals Corp.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module